May 1959

Alumni Bulletin

Summer/Fall 1984

Yale Medicine

May 1959
Alumni Bulletin

Alumni Day 1959

“Those who attended the February Alumni Day activities at the School of Medicine were privileged to hear a stimulating panel discussion on ‘Recent Advances in Cardiovascular Surgery at Yale.’ This program was arranged and moderated by Dr. William W.L. Glenn, associate director of surgery, who heads the section of cardiovascular surgery. …

“The growth of cardiovascular surgery at Yale has been possible through the integrated efforts and cooperation of various departments in the School of Medicine, and it was not possible to include all who have been active in this important field. …

“Recent advances in the diagnosis of heart disease in the adult were reviewed by Dr. Allan V.N. Goodyer (’42), associate professor of medicine, who heads the cardiovascular section of the Department of Medicine. He was followed by Dr. Richard L. Barach (’49), assistant professor of radiology, who presented a remarkable motion picture taken during fluoroscopy to illustrate cineangiography in the diagnosis of congenital heart disease. Features of various anomalies amenable to right heart bypass were discussed by Dr. Marie J. Browne, clinical fellow in rheumatic fever and heart disease, of the Department of Pediatrics.

“In conclusion, Dr. Glenn contributed some observations on the breadth and scope of cardiac surgery. A pump oxygenator (heart-lung machine) currently being used in open heart surgery was demonstrated. As a special bonus, Dr. Alexander Mauro, assistant professor of physiology, was called upon to describe a newly developed electronic cardiac pacemaker. … which recently underwent its first clinical trial successfully.”

Summer/Fall 1984
Yale Medicine

... In Progress: Cancer

“The National Cancer Institute recently awarded a grant of $421,000 for support for three years of research being conducted by Dr. Sara Rockwell on the use of perfluorochemical emulsions as adjuncts to radiotherapy. The target for this research is improved treatment of those solid tumors which are resistant even to the best of current treatment. …

“In preliminary studies, Dr. Rockwell and her colleagues have found that infusing laboratory animals that have breast cancer or sarcomas with Fluosol and having them breathe oxygen before and during radiotherapy increases the number of tumor cells killed by radiation, but does not increase the toxicity of the radiation to the blood-forming cells of bone marrow. Further studies will examine the effect of Fluosol treatment on other tumors and other normal tissues, to evaluate whether this agent in combination with radiotherapy has the potential for effective treatment of solid tumors in humans.”